- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03176589
Effect of PEP on Oxygen Saturation and Carbon Dioxide After Abdominal Surgery
Study Overview
Status
Conditions
Detailed Description
Background Hypoxia, reduced lung function and atelectais are common after abdominal surgery and can be hazardous in patients with chronic hypoxia. Positive expiratory pressure (PEP) therapy or incentive spirometry are routinely given to patients after abdominal surgery to counteract atelectasis and improve oxygen saturation. Patients are instructed by a physiotherapist to take deep inspiratory breaths and expire in a PEP-device or PEP bottle. The method is used routinely in Swedish hospital and the patient breathes against 10-15 cm water resistance. This is repeated 10x3 ie 10 deep breaths and exhalation towards PEP then rest, breath, rest and another 10 breaths. This procedure should be done once an hour after surgery. The idea is that this will widen alveoli and abolish atelectasis, thus increasing the oxygen uptake and reducing the risk of postoperative complications.
There is no evidence of effect of PEP and incentive spirometry on postoperative pulmonary complications after abdominal surgery (Guimarães MMF, Tyson AF). Nevertheless, PEP therapy is used in Sweden and internationally. There were no studies found reporting the immediate effect of PEP on continuous oxygen saturation and carbon dioxide partial pressure after surgery.
Aims
What effect does PEP have on oxygen saturation and carbon dioxide partial pressure? What is the effect of deep breathing maneuvers on oxygen saturation and carbon dioxide partial pressure?
Methods
Inclusion: 80 adult patients over 18 years of age who have undergone open or laparoscopic abdominal surgery. Patients receiving postoperative PEP are asked to participate in the study at one or two days after after abdominal surgery.
Exclusion: Patients who cannot participate in using PEP or who do not agree to participate in the study.
Power calculation:.It was estimated that 34 patients were needed to detect a mean (SD) difference in oxygen saturation of 1% (2%) and to detect a difference in transcutaneous PCO2 of 0.5 kPa (1 kPa) with a significance of p < 0.05 and a power of 80%.
Design / Randomization: RCT study with cross-over design. Patients are randomized using computer programs, handled by a person outside the study, to either start with either PEP breathing 10x3 or sham-PEP breathing 10x3.
Method: Starting with lung function assessment to determine PEF (Mini Wright Clement Clarke). Then, application of continuous transcutaneous PCO2 / SaO2 (SenTec Digital Monitoring System, ResMed) and a respiratory belt around the chest detecting the respiratory rate. Data is recorded with computer equipment (Noxturnal T3, ResMed).
The patients are randomized to initiate with either 10x3 breaths using PEP therapy or 10x3 breaths using Sham PEP. After a rest period, patients switch to the second treatment (cross-over). At the end of the trial, all patients take 10X3 deep breaths without PEP or sham PEP.
At the start of the study, baseline level for SaO2 and TcPCO2 is recorded, and an arterial blood gas is recorded to calibrate the transcutaneous PCO2 measurement. Thereafter, the registration continues during breathing / blowing until the patient returns to its baseline values. New PEF examination is made after each study arm.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Umea
-
Umeå, Umea, Sweden, 901 85
- Dept of Surgery, Inst of Surgical and Perioperative sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adult patients over 18 years of age who have undergone open or laparoscopic abdominal surgery.
- Patients receiving postoperative PEP are asked the day after surgery if they want to participate in the study.
Exclusion Criteria:
- Patients who cannot participate in using PEP or who do not agree to participate in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
SHAM_COMPARATOR: sham PEP
3 cycles of 10 deep inspiration and expiration in a sham tube without expiratory resistance
|
Deep inspirations 3 times 10 and expiration in a placebo tube without expiratory resistance
|
|
ACTIVE_COMPARATOR: PEP
3 cycles of 10 deep inspiration followed by expiration with positive expiratory pressure (PEP) device or PEP bottle of 10-15 cm of water pressure
|
Patients take a deep inspiration followed by PEP expiration with an expiratory pressure of 10-15 cm H2O
|
|
EXPERIMENTAL: deep breathing maneuvers
3 cycled of 10 deep breathing maneuvers without PEP or sham PEP
|
deep breathing maneuvers 3 times 10 breahs without any device at expiration
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Transcutaneous blood gas measurements: transcutaneous pCO2
Time Frame: once, within one hour
|
transcutaneous pCO2
|
once, within one hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pulse oximetry: oxygen saturation (SaO2)
Time Frame: once, within one hour
|
oxygen saturation (SaO2)
|
once, within one hour
|
|
Lung function: PEF
Time Frame: once, within one hour
|
Peak expiratory flow
|
once, within one hour
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Karl Franklin, Ass Prof, Umeå University
Publications and helpful links
General Publications
- Guimaraes MM, El Dib R, Smith AF, Matos D. Incentive spirometry for prevention of postoperative pulmonary complications in upper abdominal surgery. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD006058. doi: 10.1002/14651858.CD006058.pub2.
- Tyson AF, Kendig CE, Mabedi C, Cairns BA, Charles AG. The effect of incentive spirometry on postoperative pulmonary function following laparotomy: a randomized clinical trial. JAMA Surg. 2015 Mar 1;150(3):229-36. doi: 10.1001/jamasurg.2014.1846.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2017/195-31
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Gas Monitoring, Transcutaneous
-
University Hospital, GrenobleCompletedBlood Gas Monitoring, TranscutaneousFrance
-
University Hospital, Basel, SwitzerlandSenTec AG, Ringstrasse 39, CH-4106 TherwilTerminated
-
Hadassah Medical OrganizationWithdrawnBlood Gas Monitoring, TranscutaneousIsrael
-
Clinica Luganese MoncuccoOspedale Regionale Bellinzona e ValliCompletedpH | Blood Gas Monitoring, Transcutaneous | Gastric Feeding TubeSwitzerland
-
Seoul National University HospitalTerminatedAnesthesia, General | Congenital Heart Disease | Blood Gas Monitoring, Transcutaneous | Blood Gas AnalysisKorea, Republic of
-
The First Affiliated Hospital with Nanjing Medical...CompletedTranscutaneous Carbon Dioxide Partial Pressure Monitoring | Retroperitoneoscopic Urologic SurgeryChina
-
Milan MartínekCompletedHealthy | Blood Gas Monitoring, Transcutaneous | Cyclists | Penile NumbnessCzechia
-
Charite University, Berlin, GermanyCompletedSleep Apnea, Obstructive | Electroencephalography | Echocardiography | Blood Gas Monitoring, Transcutaneous | Consciousness MonitorsGermany
-
Rigshospitalet, DenmarkRadiometer Medical ApSCompletedMicrocirculation | Peripheral Perfusion | Transcutaneous Monitoring | Tissue MetabolismDenmark
-
SEFA HAKTAN HATIKEnrolling by invitationTranscutaneous Electric Nerve Stimulation | Photoplethysmography | Heart Rate Variability (HRV) | Blood Pressure Monitoring | Autonomic Nervous System (ANS) Functioning and Mood StateTurkey (Türkiye)
Clinical Trials on Placebo comparator, Deep inspiration and expression in a placebo tube without resistance
-
Allergopharma GmbH & Co. KGCompletedAllergic RhinoconjunctivitisGermany
-
Robert S Berman MDRecruitingBacterial Infections | WoundsUnited States